I don’t think there’s an antitrust problem with my proposed arrangement as long as each company unilaterally sets the price of its own drug. Co-marketing arrangements are extremely common in the pharma industry.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”